The Food and Drug Administration (FDA) has approved antiviral drug (remdesivir), corticosteroid (dexamethasone, prednisolone, and methylprednisolone), and monoclonal antibodies, particularly IL-6 antibodies (tocilizumab, siltuximab, and anakinra), for the treatment of COVID-19. Here, IL6 is linked to COVID-19.